Admission Date:  [**2144-3-17**]     Discharge Date:  [**2144-3-23**]

Date of Birth:   [**2086-6-21**]     Sex:  M

Service:  [**Company 191**]

HISTORY OF THE PRESENT ILLNESS:  Briefly, this is a
57-year-old gentleman with a history of COPD, status post
intubation six years ago but not on home 02 with recent
FEV1 27% of predicted value, and FEV1/FVC ratio 56% of
hypercholesterolemia, who was admitted for COPD exacerbation
and worsening of upper respiratory tract infection symptoms
for a week prior to admission.

He was afebrile with stable vital signs on presentation to

HOSPITAL COURSE:  He was started on p.o. steroids and
to [**Company 191**] for management of COPD exacerbation but he appeared in
more respiratory distress overnight and was started on IV
Solu-Medrol and more frequent nebulizers for COPD.  He was
also started on antibiotics for possible bronchitis or
community-acquired pneumonia.

Given his tenuous respiratory status, he was transferred to
the [**Hospital Unit Name 153**] with closer observation.  He did not require
intubation and improved with q. two hour nebulizers and chest
PT.  He was again transferred to the [**Company 191**] Service for further
management of his COPD exacerbation.  He was continued on
p.o. prednisone and frequent nebulizers for COPD.  He was
evaluated by the physical therapist in the hospital and was
found to desaturate to 84% with ambulating on room air.
Therefore, home 02 was recommended on discharge.

DISCHARGE CONDITION:  Stable.

DISCHARGE STATUS:  To home.

DISCHARGE DIAGNOSIS:
1.  Chronic obstructive pulmonary disease exacerbation.
2.  Bronchitis.
3.  Community-acquired pneumonia.
4.  Rule out myocardial infarction.

DISCHARGE MEDICATIONS:
1.  Flovent two puffs b.i.d.
2.  Levofloxacin 500 mg p.o. q.d. for another 11 days for a
total of a 14 day course.
3.  Albuterol inhaler one to two puffs q. four to six hours
p.r.n.
4.  Aspirin 81 mg p.o. q.d.
5.  Salmeterol one to two puffs b.i.d.
6.  Oxygen 2 liters nasal cannula with ambulating as needed.
7.  Prednisone taper with 40 mg p.o. q.d. for two days, 30 mg
p.o. q.d. for two days, 20 mg p.o. q.d. for two days, 10 mg
p.o. q.d. for two days.

DISCHARGE FOLLOW-UP:  The patient will see his PCP in one to
two weeks.  The patient will also see his pulmonologist, Dr.
[**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 2405**], appointment was made on discharge.




                          [**Name6 (MD) 7853**] [**Last Name (NamePattern4) 7854**], M.D.  [**MD Number(1) 7855**]

Dictated By:[**Last Name (NamePattern1) 225**]

MEDQUIST36

D:  [**2144-3-28**]  10:21
T:  [**2144-3-30**]  18:42
JOB#:  [**Job Number **]
